CytoDyn (CYDY) Short Interest Ratio & Short Volume $0.12 0.00 (-3.33%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest CytoDyn Short Interest DataCytoDyn (CYDY) has a short interest of 17.66 million shares. This marks a 2.21% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.5, indicating that it would take 4.5 days of the average trading volume of 2.55 million shares to cover all short positions.Current Short Interest17,663,800 sharesPrevious Short Interest17,281,500 sharesChange Vs. Previous Month+2.21%Dollar Volume Sold Short$1.94 millionShort Interest Ratio4.5 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares1,219,347,000 sharesPercentage of Shares Shorted1.45%Today's Trading Volume4,229,074 sharesAverage Trading Volume2,552,000 sharesToday's Volume Vs. Average166% Short Selling CytoDyn? Sign up to receive the latest short interest report for CytoDyn and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCYDY Short Interest Over TimeCYDY Days to Cover Over TimeCYDY Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now CytoDyn Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202417,663,800 shares $1.94 million +2.2%N/A4.5 $0.11 11/15/202417,281,500 shares $2.09 million +4.3%N/A3.5 $0.12 10/31/202416,577,600 shares $2.16 million +25.8%N/A2.6 $0.13 10/15/202413,179,400 shares $1.91 million +0.4%N/A2.1 $0.14 9/30/202413,133,500 shares $2.08 million +1.2%N/A3.4 $0.16 9/15/202412,982,100 shares $1.95 million +20.1%N/A2.6 $0.15 Get the Latest News and Ratings for CYDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter. 8/31/202410,806,600 shares $1.62 million +0.1%N/A3.4 $0.15 8/15/202410,797,300 shares $1.26 million +25.3%N/A1.6 $0.12 7/31/20248,617,700 shares $1.23 million +7.4%N/A3.1 $0.14 7/15/20248,024,100 shares $1.13 million +13.5%N/A2.2 $0.14 6/30/20247,070,900 shares $982,855.10 +0.1%N/A1.8 $0.14 6/15/20247,062,000 shares $947,014.20 -12.4%N/A0.8 $0.13 5/31/20248,060,300 shares $1.27 million +72.7%N/A0.8 $0.16 5/15/20244,666,400 shares $769,956.00 +0.5%N/A2.9 $0.17 4/30/20244,643,700 shares $650,118.00 -1.4%N/A2.8 $0.14 4/15/20244,711,300 shares $683,138.50 +0.7%N/A1.5 $0.15 3/31/20244,680,600 shares $764,107.95 -8.4%N/A1.6 $0.16 3/15/20245,107,100 shares $855,439.25 -1.0%N/A0.7 $0.17 2/29/20245,159,800 shares $1.33 million +9.2%N/A0.7 $0.26 2/15/20244,724,300 shares $798,595.67 -25.2%N/A0.8 $0.17 1/15/202410,691,100 shares $2.24 million -1.9%N/A3.1 $0.21 12/31/202310,893,600 shares $2.12 million +0.3%N/A1.8 $0.20 12/15/202310,863,000 shares $3.07 million -16.2%N/A1.2 $0.28 11/30/202312,960,200 shares $2.22 million 0.0%N/A2.6 $0.17 11/15/202312,965,900 shares $2.20 million -0.9%N/A6.7 $0.17 10/31/202313,087,700 shares $2.05 million +0.2%N/A5 $0.16 10/15/202313,058,200 shares $2.25 million -11.3%N/A7.5 $0.17 9/30/202314,723,600 shares $2.73 million -0.4%N/A8.3 $0.19 9/15/202314,785,400 shares $2.81 million +0.1%N/A9.2 $0.19 8/31/202314,770,500 shares $3.12 million -8.1%N/A8.6 $0.21 8/15/202316,067,600 shares $3.58 million -40.0%N/A2.2 $0.22 7/31/202326,765,000 shares $5.59 million +0.3%N/A7.8 $0.21 7/15/202326,695,600 shares $6.96 million -0.1%N/A10.5 $0.26 6/30/202326,722,500 shares $7.22 million -0.8%N/A11.1 $0.27 6/15/202326,948,200 shares $6.79 million -0.2%N/A9.9 $0.25 5/31/202327,009,000 shares $7.07 million -3.3%N/A14.2 $0.26 5/15/202327,921,000 shares $7.40 million +1.7%N/A13.9 $0.27 4/30/202327,460,800 shares $8.04 million -1.8%N/A18.5 $0.29 4/15/202327,965,300 shares $8.45 million +3.2%N/A6.7 $0.30 3/31/202327,096,500 shares $9.75 million +1.4%N/A11.2 $0.36Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> 3/15/202326,726,800 shares $10.00 million +2.4%N/A5.6 $0.37 2/28/202326,113,800 shares $8.38 million +2.7%N/A7.2 $0.32 2/15/202325,428,900 shares $7.08 million -2.7%N/A6.8 $0.28 1/31/202326,140,000 shares $6.88 million -1.5%N/A6.9 $0.26 1/15/202326,528,000 shares $6.63 million -4.1%N/A6.7 $0.25 12/30/202227,656,900 shares $6.22 million -11.7%N/A2.7 $0.23 12/15/202231,304,500 shares $10.02 million -4.6%N/A10.7 $0.32 11/30/202232,811,200 shares $11.81 million -3.3%N/A13.5 $0.36 11/15/202233,929,800 shares $13.40 million -5.0%N/A16.1 $0.40 10/31/202235,699,900 shares $12.25 million -5.1%N/A17.8 $0.34 10/15/202237,621,300 shares $16.55 million -5.9%N/A16.9 $0.44 9/30/202239,993,600 shares $16.60 million +0.7%N/A11.8 $0.42 9/15/202239,705,000 shares $24.02 million -2.1%N/A23.3 $0.61 8/31/202240,549,900 shares $21.15 million -8.8%N/A11.2 $0.52 8/15/202244,456,900 shares $36.79 million -11.7%N/A4.8 $0.83 7/31/202250,345,200 shares $38.77 million -3.5%N/A5.8 $0.77 7/15/202252,176,600 shares $22.95 million -2.1%N/A13.2 $0.44 6/30/202253,281,600 shares $22.37 million +2.4%N/A32.8 $0.42 6/15/202252,028,700 shares $20.65 million +4.6%N/A12.6 $0.40 5/31/202249,725,000 shares $15.96 million +6.3%N/A19.8 $0.32 5/15/202246,788,400 shares $15.91 million +1.6%N/A16.1 $0.34 4/30/202246,043,000 shares $14.69 million +15.1%N/A7.5 $0.32 4/15/202239,997,200 shares $10.60 million -10.4%N/A7.2 $0.27 3/31/202244,660,400 shares $16.41 million +1.0%N/A6.9 $0.37 3/15/202244,227,800 shares $17.03 million +1.1%N/A14 $0.39 2/28/202243,739,200 shares $22.39 million +3.7%N/A10 $0.51 2/15/202242,170,100 shares $24.42 million +0.5%N/A9.9 $0.58 1/31/202241,945,600 shares $22.23 million +4.6%N/A5.9 $0.53 1/15/202240,088,600 shares $27.86 million +25.5%N/A3 $0.70 12/31/202131,937,600 shares $31.58 million -1.4%N/A6.1 $0.99 12/15/202132,391,100 shares $33.52 million +5.5%N/A6.2 $1.04 11/30/202130,702,100 shares $38.38 million +0.6%N/A8.1 $1.25 11/15/202130,529,000 shares $37.70 million -7.0%N/A5.1 $1.24 10/29/202132,828,700 shares $41.04 million -7.2%N/A6.6 $1.25 10/15/202135,369,200 shares $50.22 million -9.8%N/A8.5 $1.42 9/30/202139,207,900 shares $77.63 million +2.2%N/A7.1 $1.98 9/15/202138,362,800 shares $58.50 million +2.4%N/A9.1 $1.53 8/31/202137,467,600 shares $51.71 million +2.4%N/A11.4 $1.38 8/13/202136,577,500 shares $53.95 million +1.4%N/A6.9 $1.48 7/30/202136,063,100 shares $60.95 million +2.9%N/A8.7 $1.69 7/15/202135,060,100 shares $47.93 million -2.0%N/A8.5 $1.37 6/30/202135,769,200 shares $60.81 million -4.2%N/A9.5 $1.70 6/15/202137,327,400 shares $66.44 million -4.8%N/A8.3 $1.78 5/28/202139,220,400 shares $74.52 million +4.7%N/A4.8 $1.90 5/14/202137,454,600 shares $98.13 million +0.1%N/A10 $2.62 4/30/202137,406,300 shares $104.36 million -1.4%N/A12.5 $2.79 4/15/202137,949,100 shares $108.15 million +7.3%N/A5 $2.85 3/31/202135,355,800 shares $99.70 million +11.3%N/A9.5 $2.82 3/15/202131,756,800 shares $72.61 million +38.8%N/A2.2 $2.29 2/26/202122,887,200 shares $108.03 million +5.9%N/A3.3 $4.72Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> 2/12/202121,610,000 shares $119.72 million -21.8%N/A2.2 $5.54 1/29/202127,620,400 shares $140.86 million -8.5%N/A5.2 $5.10 1/15/202127,043,500 shares $142.95 million +0.9%N/A3.9 $5.29 12/31/202028,551,500 shares $141.47 million +5.6%N/A1.7 $4.96 12/15/202027,043,500 shares $88.97 million +0.9%N/A3.9 $3.29 11/30/202026,802,300 shares $71.29 million -0.1%N/A8.5 $2.66 11/15/202026,829,000 shares $66.54 million +0.5%N/A4.1 $2.48 10/30/202026,696,700 shares $63.81 million +9.7%N/A4.7 $2.39 10/15/202024,327,000 shares $69.58 million +4.2%N/A4.6 $2.86 9/30/202023,357,800 shares $68.20 million -1.3%N/A5.4 $2.92 9/15/202023,659,300 shares $96.77 million -10.8%N/A3.3 $4.09 8/31/202026,536,800 shares $89.16 million +42.2%N/A2.3 $3.36 8/14/202018,666,200 shares $70.18 million +41.0%N/A2.3 $3.76 7/31/202013,240,400 shares $65.86 million +38.2%N/A1.2 $4.97 7/15/20209,577,900 shares $46.45 million -6.6%N/A0.5 $4.85 6/30/202010,252,400 shares $89.91 million +11.1%N/A0.7 $8.77 6/15/20209,230,700 shares $28.52 million -6.4%N/A1.9 $3.09 5/29/20209,858,200 shares $27.80 million +3.4%N/A1.5 $2.82 5/15/20209,536,700 shares $28.61 million +10.3%N/A0.9 $3.00 4/30/20208,650,000 shares $28.07 million +6.5%N/A0.7 $3.25 4/15/20208,119,200 shares $20.38 million +11.4%N/A0.4 $2.51 3/31/20207,287,900 shares $23.18 million +34.0%N/A1.3 $3.18 3/13/20205,440,900 shares $15.67 million -10.8%N/A1.4 $2.88 2/28/20206,100,100 shares $6.10 million -3.3%N/A1.4 $1.00 2/14/20206,311,200 shares $6.50 million +15.8%N/A0.5 $1.03 1/31/20205,451,900 shares $5.94 million +49.5%N/A1.2 $1.09 1/15/20203,647,100 shares $4.38 million +34.1%N/A0.7 $1.20 12/31/20192,720,300 shares $2.97 million +2,191.7%N/A0.4 $1.09 CYDY Short Interest - Frequently Asked Questions What is CytoDyn's current short interest? Short interest is the volume of CytoDyn shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 17,663,800 shares of CYDY short. Learn More on CytoDyn's current short interest. What is a good short interest ratio for CytoDyn? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CYDY shares currently have a short interest ratio of 4.0. Learn More on CytoDyn's short interest ratio. Is CytoDyn's short interest increasing or decreasing? CytoDyn saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 17,663,800 shares, an increase of 2.2% from the previous total of 17,281,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CytoDyn's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CytoDyn: Tectonic Therapeutic (6.13%), Stoke Therapeutics, Inc. (12.71%), CARGO Therapeutics, Inc. (17.64%), Altimmune, Inc. (32.94%), Exscientia plc (2.55%), Terns Pharmaceuticals, Inc. (8.67%), ORIC Pharmaceuticals, Inc. (16.00%), Phathom Pharmaceuticals, Inc. (20.55%), Tourmaline Bio, Inc. (10.84%), Ginkgo Bioworks Holdings, Inc. (20.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short CytoDyn stock? Short selling CYDY is an investing strategy that aims to generate trading profit from CytoDyn as its price is falling. CYDY shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CytoDyn? A short squeeze for CytoDyn occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYDY, which in turn drives the price of the stock up even further. How often is CytoDyn's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYDY, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies TECX Short Interest STOK Short Interest CRGX Short Interest ALT Short Interest EXAI Short Interest TERN Short Interest ORIC Short Interest PHAT Short Interest TRML Short Interest DNA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CYDY) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytoDyn Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytoDyn With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYDY Stock Alerts